StockData
WRBYNYSEOphthalmic GoodsFiscal year ends December 31

Warby Parker Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$24.99+1.65 (+7.07%)

Close on Oct 19, 2026

Market cap
$3.14B
P/E (TTM)
357.0
Dividend yield
–

Warby Parker Inc. revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Eyewear$191.76M$201.44M$99.49M$207.22M$176.86M$187.86M$100.03M$182.17M$179.21M$190.64M$104.38M$159.80M81.4%+8.4%
Contacts$26.60M$24.18M––$24.65M$22.99M––––––11.3%+7.9%
Eye care$17.15M$16.82M––$12.97M$12.94M––––––7.3%+32.2%
Eye care––$15.32M$14.46M$12.97M$12.94M$11.86M$10.28M$9.01M$9.36M$13.08M$10.05M––

By region

From the segment and revenue-disaggregation notes of Warby Parker's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.